Published As:
US2012252736
Title:
METHODS INVOLVING PDGFRBETA INHIBITORS
Value Drivers by Geography
Seller defined
PCT Application Office Action Grant
United States
PCT
Europe
PCT
Japan
PCT
Patent Cooperation Treaty
PCT
Rest of the World
flag
Patent PDF
Figure
Figure 1 - US2012252736
Priority Date
28
Sep
10
Share
Abstract:
The invention refers to PDGFRbeta inhibitor for use in the antiproliferative treatment of T-cell lymphoma, in particular NHL, ALCL and PTCL.
Claim 1:
A method of treating a patient with T-cell lymphoma and susceptible to a cell proliferative disorder comprising: obtaining a PDGFRbeta inhibitor; and administering the PDGFRbeta inhibitor to the patient.